8-K filings / November 16, 2026
Aspira Women's Health Inc.: Financial statements that should no longer be relied upon
Aspira Women's Health Inc. filed a current report (Form 8-K) with the SEC on November 16, 2026. It reports financial statements that should no longer be relied upon.
AI-written from the facts below
In plain English
On November 13, 2026, the audit committee concluded that financial statements the company issued earlier for the three and six months ended March 31, and June 30, 2026, should no longer be relied upon. The filing states that this restatement reflects the correction of how a loan obtained in January 2026 and related payments were recorded, as they were previously reported within operating activities in the Statement of Cash Flows rather than financing activities.
What each sentence states
“On November 13, 2026, the audit committee concluded that financial statements the company issued earlier for the three and six months ended March 31, and June 30, 2026, should no longer be relied upon.”
- Item 4.02 of Form 8-K covers a company's conclusion that financial statements it issued earlier should no longer be relied upon.
- Item 4.02: the company says that financial statements it issued earlier should no longer be relied upon.
- Item 4.02: this was concluded on November 13, 2026.
- Item 4.02: it was concluded by the audit committee.
- Item 4.02: the statements no longer to be relied upon include those for: three and six months ended March 31, and June 30, 2026.
“The filing states that this restatement reflects the correction of how a loan obtained in January 2026 and related payments were recorded, as they were previously reported within operating activities in the Statement of Cash Flows rather than financing activities.”
- Item 4.02: the reason the filing gives, in its own words: "Specifically, the restatement reflects the correction of the recording of a loan obtained in January 2026 and related payments that were previously reported within operating activities in the Statement of Cash Flows rather than financing activities.".
Item 4.02
Financial statements no longer to be relied upon
-
Conclusion
Earlier financial statements should no longer be relied upon
From the filing
Source
“On November 13, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Aspira Women’s Health Inc. (the “Company”), after discussion with management and the Company’s independent registered public accounting firm, concluded that the Company’s previously issued unaudited Condensed Consolidated Financial Statements as of and for the three and six months ended March 31, and June 30, 2026 (the “Affected Periods”) included in the Company’s Quarterly Reports on Form 10-Q filed on May 15, 2026, and August 14, 2026, should no longer be relied upon due to material errors in the unaudited Condensed Consolidated Statement of Cash Flows.”
Read by code from this sentence of the filing. -
Concluded on
November 13, 2026
From the filing
Source
“On November 13, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Aspira Women’s Health Inc. (the “Company”), after discussion with management and the Company’s independent registered public accounting firm, concluded that the Company’s previously issued unaudited Condensed Consolidated Financial Statements as of and for the three and six months ended March 31, and June 30, 2026 (the “Affected Periods”) included in the Company’s Quarterly Reports on Form 10-Q filed on May 15, 2026, and August 14, 2026, should no longer be relied upon due to material errors in the unaudited Condensed Consolidated Statement of Cash Flows.”
Read by code from this sentence of the filing. -
Concluded by
The audit committee
From the filing
Source
“On November 13, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Aspira Women’s Health Inc. (the “Company”), after discussion with management and the Company’s independent registered public accounting firm, concluded that the Company’s previously issued unaudited Condensed Consolidated Financial Statements as of and for the three and six months ended March 31, and June 30, 2026 (the “Affected Periods”) included in the Company’s Quarterly Reports on Form 10-Q filed on May 15, 2026, and August 14, 2026, should no longer be relied upon due to material errors in the unaudited Condensed Consolidated Statement of Cash Flows.”
Read by code from this sentence of the filing. -
Period
three and six months ended March 31, and June 30, 2026
From the filing
Source
“On November 13, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Aspira Women’s Health Inc. (the “Company”), after discussion with management and the Company’s independent registered public accounting firm, concluded that the Company’s previously issued unaudited Condensed Consolidated Financial Statements as of and for the three and six months ended March 31, and June 30, 2026 (the “Affected Periods”) included in the Company’s Quarterly Reports on Form 10-Q filed on May 15, 2026, and August 14, 2026, should no longer be relied upon due to material errors in the unaudited Condensed Consolidated Statement of Cash Flows.”
Read by code from this sentence of the filing. -
Reason given
Specifically, the restatement reflects the correction of the recording of a loan obtained in January 2026 and related payments that were previously reported within operating activities in the Statement of Cash Flows rather than financing activities.
From the filing
Source
“Specifically, the restatement reflects the correction of the recording of a loan obtained in January 2026 and related payments that were previously reported within operating activities in the Statement of Cash Flows rather than financing activities.”
Found by an AI model; the quote is checked word for word against the filing.
Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.